CLINICAL_TRIALS
trial_result
· 2019-01-04
Clinical Trial Update: Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab [Phase 3]
Summary
Phase 3 trial update on efficacy and safety of secukinumab for palmoplantar pustular psoriasis with completed status and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Palmoplantar Pustular Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-01-04